ArticleAAPS PharmSciTech2025
A Novel End-to-End Simulation Framework for Internal Flow in pMDIs: Coupled Modeling of Cavitation, Flash Boiling, and Atomization.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pressurized metered dose inhalers (pMDIs) are among the most commonly prescribed inhalation devices; yet their performance often remains suboptimal. Although the inefficiencies of these inhalers have been recognized for a long time, the absence of a comprehensive numerical model that spans the entire process-from propellant injection to aerosol plume formation-has hindered efforts to identify the underlying causes of these issues. This study presents a novel multiphase framework based on the volume of fluid (VOF) approach, which captures key internal flow phenomena in pMDIs, including cavitation, flash boiling, and atomization. The model was validated using plume visualization data obtained via high-speed imaging, complemented by high-resolution X-ray imaging from prior in vitro studies. The proposed numerical framework demonstrates predictive capability by reproducing key plume characteristics in close agreement with multiple independent experimental datasets. It yields a mass median diameter of approximately 2.7 μm, which closely aligns with the experimental value of 3 μm. Additionally, the model captures the dynamics of the spray, predicting an initial velocity of around 110 m/s and a cone angle of approximately 21°. These predictions are in excellent agreement with the high-speed imaging data obtained in this study. By moving beyond one-size-fits-all approaches, this platform enables the optimization and adaptation of inhaler configurations based on formulation-specific performance criteria, offering a promising tool to support the development of pMDIs tailored to a broad range of therapeutic applications.
Indexed as
Identifiers
41199114What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.